Resources for Health Care Providers

Photo of smiling doctor

Every health care provider can help mitigate the spread of viruses, including COVID-19. Find resources below, and let us know if you have questions. 

Provider Advisories Isolation and Quarantine
Treatments Additional Resources
Testing Vaccines


Provider Advisories

Public Health issues time-sensitive public health updates to health care providers. See the most recent advisories below. 

Sign Up to Receive Provider Advisories

01-30-2024-When-to-Administer-RSV-Immunizations Reminder of timeframes to administer the maternal RSV vaccine and the monoclonal antibody immunization for infants.
02-08-2024-Referring-WIC-Patients-for-Medical-Formula-or-Nutritionals CDPH has created new resources to assist health care providers when referring to WIC for therapeutic formulas.
01-30-2024-When-to-Administer-RSV-Immunizations_advisory Timeframes of when to administer the maternal RSV vaccine and the RSV immunization for infants.
01-23-2024-Substantial-Rise-in-Valley-Fever-in-California An advisory from the California Department of Public Health (CDPH) shares recommendations for health care providers as a record-breaking number of Valley Fever cases appear in California.
01-09-2024-Updated-CDC-Guidance-Increased-Supply-of-Nirsevimab-for-RSV-Season-2023-2024 Increased Supply of Nirsevimab for RSV Season 2023-2024

View All Provider Advisories

California Health Alert Network (CAHAN)

CAHAN is California’s web-based information and communications system for distributing health alerts, disseminating treatment and guidelines, coordinating disease investigation efforts, preparedness planning, and other initiatives that strengthen state and local preparedness.

Visit website


COVID-19 Treatments


Questions about prescribing treatment? California health care providers can now call the COVID-19 Therapeutics Warmline at (866) 268-4322 (COVID-CA) to receive free, real-time, confidential consultation on COVID-19 testing and treatment. Available Monday – Friday, 6 am – 5 pm; managed by the UCSF National Clinician Consultation Center.


Many patients with COVID-19 can recover at home without prescription treatment. But for some people who have certain health conditions or who are aged 50 and older, prescription treatment may be an important help.

Currently, health care providers in SLO County are encouraged to prescribe treatment of SARS-CoV-2 for any eligible individual (patients infected with COVID-19 of ages 50+ or any age with health conditions that increase the risk for severe COVID-19). As of February 1, the FDA updated their EUAs of Paxlovid and Lagevrio (Molnupiravir) to remove the requirement for a positive SARS-CoV-2 test to reduce barriers for timely prescribing and dispensing of COVID-19 treatment. 

Treatment within the first 24-48 hours of symptom onset is ideal.  Encourage your patients to test for COVID-19 early (at the first symptoms) and five days after a known exposure or large gathering. 

See COVID-19 Treatments

NIH has released treatment guidelines for the therapeutic management of non-hospitalized adults with COVID-19. It includes several options:

Paxlovid (nirmatrelvir tablets and ritonavir tablets), is the #1 recommended treatment right now. Studies show it’s highly effective at preventing hospitalization and death when started early. It is in ample supply at multiple pharmacies across SLO County and through Community Health Centers of the Central Coast (CHC). See a list of pharmacies at See the FDA Fact Sheet for Healthcare Providers. Or, see the Paxlovid Eligibility and Effectiveness Information Sheet.

Remdesivir is the only COVID-19 medication treatment option for individuals less than 12 years of age. This intravenous medication is currently in adequate supply, and health care providers may order it directly from an authorized distributor. In addition to hospital settings, it may now be provided in skilled nursing facilities, home healthcare settings and outpatient facilities such as infusion centers. The Public Health Department can provide technical assistance to providers who wish to begin administering this medication to outpatients.  

Lagevrio (molnupiravir capsules) has received emergency use authorization for people at high risk for severe illness for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate. See the FDA Fact Sheet for Healthcare Providers. Or, see the Lagevrio (Molnupiravir) Eligibility and Effectiveness Information Sheet .

In the event of logistical constraints or low treatment supply, providers may follow guidelines from the National Institutes of Health COVID-19 Treatment Guidelines for Patient Prioritization for non-hospitalized patients.


The FDA has also recently granted EUA for a monoclonal antibody for critically ill hospitalized patients:

Gohibic (vilobelimab) is an injection for treating COVID-19 in hospitalized adults, initiated within 48 hours patients of receiving artificial life support (invasive mechanical ventilation or extracorporeal membrane oxygenation). See the FDA Gohibic (vilobelimab) Emergency Use Authorization (EUA) Sheet


Where to find COVID-19 treatments locally: 


Telehealth COVID-19 treatment service for Californians: 

Patients who don't have health insurance or aren't able to see their regular health care provider within 24 hours can see a doctor at no cost via telehealth (computer, cell phone, or landline). This program from the State of California is for people who have tested positive and have symptoms.  To make an appointment, patients may visit or call 833-686-5051.


For more information about treatments: 


COVID-19 Testing

COVID-19 Testing for Patients. Please visit for resources, including no-cost COVID-19 test kits.

COVID-19 Testing for Medical Providers. Please use the COVID-19 Testing Referral Form to request testing for medical providers in SLO County. 

Outbreak Response Testing and Other Testing Support. For consultation regarding response to an outbreak, please contact [email protected] or call 805-781-5500. For questions regarding testing support and supplies, please contact [email protected].
Find COVID-19 Testing 


Please use the COVID-19 Confidential Morbidity Report to report a case of COVID-19. 

Report a COVID-19 Case


Isolation and Quarantine

Providers may refer to isolation and quarantine guidance when advising patients on their isolation and quarantine requirements and duration.

See Isolation and Quarantine Guidance


Additional Resources for You and Your Patients

Print Resources for Your Practice

Below are some print resources to communicate information about COVID-19 and the COVID-19 vaccine. Below you will find ready-to-use resources that can be shared with the populations you work with. Not seeing the information that you need?  Contact us and let us know!

Face masks signs

English |Spanish


Photo of keep your distance sign

Keep your distance signs

English | Spanish

Vaccine timing chart

English | Spanish

Photo of vaccine poster

Vaccine Posters

English | Spanish

Photo of brochures


See brochures here.


Photo of surgeon general toolkit

Surgeon General's

Toolkit on Misinformation

View the toolkit



More Resources



Vaccines continue to be the best line of defense against COVID-19 and CDC recommends everyone six months and older get a COVID-19 Vaccine. There is a great deal of reassuring data on the safety and effectiveness of COVID-19 vaccines.

See CDPH Vaccination Guidance

Bridge Access Program COVID-19 vaccines are available through For Children COVID-19 vaccines are available through

To learn more about the commercialization of COVID-19 vaccines, see Commercialiation at a GlanceCOVID-19 Vaccine Commercialization FAQs, or the HHS Commercialization Transition Guide.

Vaccine Updates

Vaccine schedules

More Vaccine Resources: